Chi Ma

机构：National Institutes of Health, Union Hospital, Nankai University, Sheng Jing Hospital, Yuhuangding Hospital, Shandong Provincial Hospital, Lanzhou University Second Hospital, National Cancer Institute, Jiangsu Hengrui Medicine (China), Center for Cancer Research, Shandong First Medical University, Huazhong University of Science and Technology, Lanzhou University · ORCID：0000-0002-4171-0813

发表论文 199 篇 · 总被引 18862 次 · h-index 46

代表论文

• SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases (2025 · Nature Communications · 被引 57)
• Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME (2025 · Immunity · 被引 34)
• Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab (2025 · Gut · 被引 21)
• Multi-omics and network pharmacology approaches reveal Gui-Ling-Ji alleviates oligoasthenoteratozoospermia by regulating arachidonic acid pathway (2024 · Phytomedicine · 被引 16)
• Methionine Dependency and Restriction in Cancer: Exploring the Pathogenic Function and Therapeutic Potential (2025 · Pharmaceuticals · 被引 12)
• Lipid accumulation inhibition strategies alleviate Fusobacterium nucleatum-infected colorectal cancer (2025 · Microbiome · 被引 7)